HFpEF in the Eyes of the European and U.S. Guidelines
[Speaker] Stuart Prenner / Univ. of Pennsylvania, USA
Discussion
Therapies for HFpEF: The Impact of SGLT2 Inhibitors and ARNI’s on the Disease Process
[Speaker] Jaewon Oh / Yonsei Univ., Korea
Discussion
Non-Pharmacological Approaches to Improving Symptoms and Exercise Capacity
[Speaker] Jagmeet Singh / Harvard Medical School, USA
Discussion